March 7, 2017 / 9:58 PM / 5 months ago

BRIEF-Axsome Therapeutics Q4 loss per share $0.38

March 7 (Reuters) - Axsome Therapeutics Inc:

* Axsome Therapeutics reports fourth quarter and full year 2016 financial results and provides business update

* Q4 loss per share $0.38

* Q4 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

* Axsome Therapeutics - believes cash at Dec 31, 2016 will be sufficient to fund anticipated operations, based on current operating plans, through Q1 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below